Equity Overview
Price & Market Data
Price: $28.31
Daily Change: -$0.42 / 1.48%
Daily Range: $26.50 - $29.94
Market Cap: $892,447,040
Daily Volume: 388,983
Performance Metrics
1 Week: 1.54%
1 Month: 50.19%
3 Months: 40.22%
6 Months: 64.12%
1 Year: 64.12%
YTD: 65.36%
Company Details
Employees: 41
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is based in Palo Alto, California.